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A B S T R A C T
The purpose of the paper was to describe general health, socio-economic and demo-
graphic characteristics of postmenopausal estrogen users in comparison to nonusers.
During years 1994–2000, 717 postmenopausal estrogen users and 235 postmenopausal
nonusers were gynecological examined, interweaved with a questionnaire including in-
formation on their health, socio-economic and demographic status and compared.
Women who had prescription on a hormone replacement minimally 6 months before in-
terview were deemed to be current users, but the controls had not use hormone replace-
ment ever. Hormone replacement users were statistically significant more often smokers,
they had better physical activity and better general health than nonusers. Women with
surgical menopause were more often hormone replacement users than nonusers. Women
with better socio-economic status, higher education and urban population were more
likely to use hormone replacement. Single, divorced and widowed women were more
likely, but married women were less likely to use hormone replacement. However, more
healthy profiles among hormone replacement users may inflate the apparent benefit of
treatment. The gynaecologists play a major role in hormone replacement therapy deci-
sion-making because of a substantial public health impact.
Introduction
Menopause is customarily defined, for
statistical and epidemiological purposes,
as the absence of menses for one year.
Also, it is adult-onset ovarian failure,
with the loss of estrogens, progesterone
and ovarian androgens1. Hormone re-
placement therapy (HRT) is increasingly
used to alleviate climacteric symptoms
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caused by estrogen deficiency in postme-
nopausal women2. Long-term use of HRT
is known to reduce the risk of osteoporo-
sis, cardiovascular disease, dementia and
carbohydrate intolerance3–11.
Although some studies have sugges-
ted that postmenopausal women taking
estrogen have more healthy profiles than
nonusers12. Finally, postmenopausal women
using estrogen tend to be more highly ed-
ucated and have higher incomes than do
postmenopausal women not using estro-
gen8.
Surprisingly little is known about the
prevalence of use or characteristics of
women using HRT. Therefore, the study
provides to describe general health,
socio-economic and demographic charac-
teristics of HRT use in the postmenopa-
usal population and compared with non-
users.
Subjects and Methods
The subjects were recruited from post-
menopausal women undergoing the regu-
lar gynecological checkups during years
1994–2000. There were 717 postmeno-
pausal users of HRT and 235 postme-
nopausal nonusers. In the users group
there were 244 (34%) patients with previ-
ous hysterectomy and oophorectomy, and
they had been given unopposed estro-
gens. On the other hand, other non-oper-
ated users had received combined treat-
ments with the progestogen component.
Women who had a prescription for HRT
minimally in the 6 months before inter-
view were deemed to be current users,
but the controls had not use HRT ever.
All subjects were gynecological examined
and interviewed with a questionnaire in-
cluding information on their health, gy-
necological history, socio-economic and
demographic factors. Information col-
lected at recruitment included details of
age, height, weight, cigarette and alcohol
consumption, past medical history and
previous surgery, physical activity, parity,
education and socio-economic status.
Each woman was categorized by her re-
ported details or symptoms.
For comparisons of metric or categori-
cal variables between patients and con-
trol subjects Student t test or 2 test was
used. In single variable comparisons the
p values less than 0.05 were considered
statistically significant.
Results
The control subjects were anthropo-
metricaly matched to the patients (Table
1), and the differences in the number of
parity between HRT users and controls
were not observed. The postmenopause
endured statistically significant longer in
the nonusers group (p=0.011). Women
with surgical menopause were more often
HRT users than nonusers (p<0.05). Also,
HRT users were statistically significant
more often smokers (p<0.005), they had
better physical activity (p<0.001) and
better general health (p<0.001) than non-
users. The difference between alcohol
consumption HRT users and nonusers
were not observed (p=0.15) (Table 1).
Table 2 shows socio-demographic cha-
racteristics of HRT users and nonusers.
Women with better socio-economic status
were more likely to use HRT (p<0.001),
also urban population (p<0.001). Educa-
tional status, measured by school leaving
age, was significantly associated with the
use of HRT (p<0.001) (Table 2). Single,
widowed and divorced women were more
likely to use HRT (p<0.05), but married
women were less likely to use HRT (p<
0.001) (Table 2).
Discussion
The favorable effects of HRT are well
established, although continuous – com-
bined HRT provides good endometrial
safety withdrawal bleeding. Fluctuations
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in the use of postmenopausal estrogen
over time appear to have followed reports
about its potential risks and benefits12,13.
Inadequate information exists to recom-
mend for or against HRT, and past stud-
ies report that between 5% and 30% of
postmenopausal women are current us-
ers of hormone replacement13–15. Little is
known about the characteristics of
women using HRT. Several studies have
suggested that women of higher educa-
tional or socio-economic status are more
likely to use HRT than those of lower
status12–14. Another studies only found
that the indications for HRT are clearer
in women with a hysterectomy, and
therefore less prone to other influences
such as social or cultural factors15,16. Evi-
dence for an association between smoking
and HRT use are also inconsistent. Some
studies have found that smokers were
more likely to receive these treatments
than nonsmokers12,17, others have not15–18.
In our study smokers were more likely to
be prescribed HRT than nonsmokers, but
alcohol consumers did not. It is not sur-
prising that a reported history of surgical
menopause increased the chances of a
woman being given HRT, and similar
findings were observed by others16. Our
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TABLE 1
CLINICAL AND ANTHROPOMETRIC PROFILES OF POSTMENOPAUSAL HORMONE






Age (years, mean ± SD) 56.8 ± 7.1 57.1 ± 6.9 0.572b
Height (cm, mean ± SD) 165 ± 5.9 164 ± 5.4 0.122b
Weight (kg, mean ± SD) 64.7 ± 7.2 64.3 ± 6.9 0.456b
Parity (%)
0 7 8 0.411a
1 – 2 66 63 0.458a
 3 26 30 0.416a
Duration of postmenopausis
(years, mean ± SD) 4.7 ± 1.9 5.2 ± 2.4 0.011b
Surgical menopause (%)
Yes 34 26 < 0.05a
No 66 74 < 0.05a
Smoking (%)
Yes 42 31 < 0.005a
No 58 69 < 0.05a
Alcohol consumption (%)
Yes 24 17 0.15a
No 76 83 0.08a
Physical activity (%)
Active 43 29 < 0.001a
Inactive 57 71 < 0.01a
General health (%)
Very good 27 17 < 0.001a
Good 59 41 < 0.001a
Bad 11 28 < 0.001a
Very bad 3 14 < 0.001a
a = 2-test; b = t-test
findings are similarly to results of others.
In our study HRT users had had more
physical activity and their general health
was significant better than of nonusers.
Also, our HRT users were predominantly
urban women, and their socio-economic
status was significantly better than of
nonusers. The women of users group
were average better education than non-
users. Single, widowed and divorced
women were more likely to use HRT, but
married women were less likely to use
HRT. Our findings on socio-demographic
variations in use of HRT are consistent
with other studies8,16.
In summary, postmenopausal HRT us-
ers appeared to have more healthy life-
styles than did nonusers in terms of exer-
cise and general health, but did not in
terms of smoking and alcohol consump-
tion. Also, socio-economic and educa-
tional status of HRT users were better
than of nonusers. We cannot, from our
study, identify the reasons for differences
in prescribing, but the role of professional
attitudes primary care physicians and gy-
necologists need to be explored. It is also
possible prescription costs act as a bar-
rier to use of HRT. The little number
studies of this kind facts shows that the
gynecologist play a major role in hormone
replacement therapy decision-making.
These data may be relevant for future be-
cause hormone replacement therapy
practices will have a substantial public
health impact.
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TABLE 2
SOCIO-DEMOGRAPHIC CHARACTERISTICS OF POSTMENOPAUSAL HORMONE







Very good 26 12 < 0.001
Good 56 44 < 0.01
Bad 16 31 < 0.001
Very bad 2 13 < 0.001
Educational status (%)
Low 8 27 < 0.001
Medium 53 64 < 0.05
High 39 9 < 0.001
Urban (%) 83 65 < 0.001
Rural (%) 17 35 < 0.001
Marital status (%)
Married 46 67 < 0.001
Single 11 6 < 0.05
Widowed 34 23 < 0.05
Divorced 9 4 < 0.001
*= 2-test
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SOCIO-DEMOGRAFSKE OSOBITOSTI KORISNICA ESTROGENSKOG
NADOMJESNOG LIJE^ENJA U POSLIJEMENOPAUZI
S A @ E T A K
Cilj rada je bio ispitati zdravstveno stanje, socijalno-ekonomske i demografske ka-
rakteristike korisnica hormonskog nadomjesnog lije~enja u poslijemenopauzi i uspore-
diti ih s poslijemenopauzalnim `enama koje takvu terapiju nisu koristile. Izme|u
1994–2000 godine ispitano je 717 poslijemenopauzalnih korisnica hormonskog nado-
mjesnog lije~enja i uspore|eno s 235 ne-korisnica u poslijemenopauzi, i to ginekolo-
{kim pregledima i anketnim listi}em koji je sadr`avao informacije o zdravstvenom,
socijalno-ekonomskom i demografskom stanju. Korisnice su bile `ene koje su hormon-
sko nadomjesno lije~enje uzimale najmanje 6 mjeseci, a ne-korisnice one koje takvu te-
rapiju nisu nikad koristile. Korisnice hormonskog nadomjesnog lije~enja zna~ajno
~e{}e bile su pu{a~ice, bile su fizi~ki aktivnije i boljeg op}eg zdravstvenog stanja nego
ne-korisnice. @ene koje su kirur{ki kastrirane ~e{}e su koristile hormonsko nadomjes-
no lije~enje. @ene boljeg socijalno-ekonomskog stanja, vi{e naobrazbe i stanovnice gra-
da ~e{}e su se odlu~ivale na hormonsko nadomjesno lije~enje. Udate `ene rje|e su se
odlu~ivale na ovu terapiju, a one koje `ive same, udovice i razvedene, zna~ajno ~e{}e.
Zdraviji profil korisnica hormonskog nadomjesnog lije~enja mo`e la`no prikazati bolju
korist ove terapije. Ginekolog igra zna~ajnu ulogu u pacijentovoj odluci za terapijom,
jer ona je va`an dio javno-zdravstvenih programa.
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